JP7832104B2 - ヒアルロン酸産生促進剤 - Google Patents

ヒアルロン酸産生促進剤

Info

Publication number
JP7832104B2
JP7832104B2 JP2022517057A JP2022517057A JP7832104B2 JP 7832104 B2 JP7832104 B2 JP 7832104B2 JP 2022517057 A JP2022517057 A JP 2022517057A JP 2022517057 A JP2022517057 A JP 2022517057A JP 7832104 B2 JP7832104 B2 JP 7832104B2
Authority
JP
Japan
Prior art keywords
hyaluronic acid
magnesium
acid production
skin
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2022517057A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2021215440A1 (https=
Inventor
真紀子 新妻
雄治 勝田
彰 五十里
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shiseido Co Ltd
Original Assignee
Shiseido Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shiseido Co Ltd filed Critical Shiseido Co Ltd
Publication of JPWO2021215440A1 publication Critical patent/JPWO2021215440A1/ja
Application granted granted Critical
Publication of JP7832104B2 publication Critical patent/JP7832104B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Birds (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Polymers & Plastics (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Nutrition Science (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
JP2022517057A 2020-04-22 2021-04-20 ヒアルロン酸産生促進剤 Active JP7832104B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2020076345 2020-04-22
JP2020076345 2020-04-22
PCT/JP2021/016058 WO2021215440A1 (ja) 2020-04-22 2021-04-20 ヒアルロン酸産生促進剤

Publications (2)

Publication Number Publication Date
JPWO2021215440A1 JPWO2021215440A1 (https=) 2021-10-28
JP7832104B2 true JP7832104B2 (ja) 2026-03-17

Family

ID=78269414

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022517057A Active JP7832104B2 (ja) 2020-04-22 2021-04-20 ヒアルロン酸産生促進剤

Country Status (3)

Country Link
JP (1) JP7832104B2 (https=)
CN (1) CN115315242A (https=)
WO (1) WO2021215440A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2026003274A1 (en) * 2024-06-28 2026-01-02 Unilever Ip Holdings B.V. Skin care benefit cosmetic compositions

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004075629A (ja) 2002-08-21 2004-03-11 Kanebo Ltd 化粧料
JP2005514059A (ja) 2001-06-13 2005-05-19 ザ ボード オブ リージェンツ オブ ザ ユニヴァーシティー オブ オクラホマ ヒアルロナンシンターゼ遺伝子およびそれらの発現
US20080038219A1 (en) 2006-08-07 2008-02-14 Calgenex Corporation Novel Composition for a Topical Skin Treatment Base and Medicated Applications Thereof
JP2010013378A (ja) 2008-07-02 2010-01-21 Mandom Corp 皮膚外用剤組成物
JP2010037287A (ja) 2008-08-06 2010-02-18 Kaneka Corp 還元型補酵素ｑ及びｎ−アセチルグルコサミン含有組成物
CN101935679A (zh) 2010-03-04 2011-01-05 上海交通大学 基于革兰氏阳性安全微生物的透明质酸的异源合成方法
JP2011190286A (ja) 2010-03-11 2011-09-29 Yokohama Rubber Co Ltd:The ホットメルト接着剤組成物
JP2012001457A (ja) 2010-06-15 2012-01-05 Toyo Beauty Kk 抗しわ剤および抗老化性化粧料
JP6208066B2 (ja) 2014-03-31 2017-10-04 富士フイルム株式会社 組成物、皮膚外用剤、化粧料、及び飲食品

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08183708A (ja) * 1994-12-28 1996-07-16 Osaka Yakuhin Kenkyusho:Kk しみ・くすみ除去化粧料組成物
JP4425554B2 (ja) * 2003-03-19 2010-03-03 日本メナード化粧品株式会社 皮膚外用剤
JP2006204260A (ja) * 2005-01-31 2006-08-10 Toyobo Co Ltd ヒアルロン酸合成酵素及びその遺伝子
US20070092469A1 (en) * 2005-10-26 2007-04-26 Eric Jacobs Topically applied Glucosamine Sulfate and all its related, precursor, and derivative compounds significantly increases the skin's natural produciton of hyaluronic acid for the rejuvenation of healthier younger-looking skin; while PhosphatidylCholine is required to replace its deficiency caused by topical Dimethylaminoethanol (DMAE)
US20080138865A1 (en) * 2006-07-06 2008-06-12 Reliance Life Sciences Pvt. Ltd. Optimisation of culture conditions for production and process of purification of high molecular weight hyaluronic acid
JP2011190186A (ja) * 2010-03-12 2011-09-29 Nicca Chemical Co Ltd アクアポリン３産生促進剤、及びそれを含有する化粧料
CN103908415B (zh) * 2014-04-18 2016-06-29 美晨集团股份有限公司 一种面膜及其制备方法
CN108719998A (zh) * 2017-04-24 2018-11-02 中南大学湘雅医院 一种用于治疗骨关节炎的口服膳食补充药剂

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005514059A (ja) 2001-06-13 2005-05-19 ザ ボード オブ リージェンツ オブ ザ ユニヴァーシティー オブ オクラホマ ヒアルロナンシンターゼ遺伝子およびそれらの発現
JP2004075629A (ja) 2002-08-21 2004-03-11 Kanebo Ltd 化粧料
US20080038219A1 (en) 2006-08-07 2008-02-14 Calgenex Corporation Novel Composition for a Topical Skin Treatment Base and Medicated Applications Thereof
JP2010013378A (ja) 2008-07-02 2010-01-21 Mandom Corp 皮膚外用剤組成物
JP2010037287A (ja) 2008-08-06 2010-02-18 Kaneka Corp 還元型補酵素ｑ及びｎ−アセチルグルコサミン含有組成物
CN101935679A (zh) 2010-03-04 2011-01-05 上海交通大学 基于革兰氏阳性安全微生物的透明质酸的异源合成方法
JP2011190286A (ja) 2010-03-11 2011-09-29 Yokohama Rubber Co Ltd:The ホットメルト接着剤組成物
JP2012001457A (ja) 2010-06-15 2012-01-05 Toyo Beauty Kk 抗しわ剤および抗老化性化粧料
JP6208066B2 (ja) 2014-03-31 2017-10-04 富士フイルム株式会社 組成物、皮膚外用剤、化粧料、及び飲食品

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Sexy Look，The Power of Enzyme Mask，Mintel GNPD [online]，2018年03月，<https://portal.mintel.com>，ID#5522431, [取得日 2025.06.19], 表題部分及び成分

Also Published As

Publication number Publication date
JPWO2021215440A1 (https=) 2021-10-28
WO2021215440A1 (ja) 2021-10-28
CN115315242A (zh) 2022-11-08

Similar Documents

Publication Publication Date Title
CN101291651B (zh) 用于毛发生长的外用组合物
KR102042967B1 (ko) 푸코실락토오스를 포함하는 피부 노화 개선용 화장료 조성물
CN111135124B (zh) 含有蔗糖、吲哚-3-乙酸以及玫瑰果提取物的混合物的皮肤外用剂组合物
EP1841404A1 (en) Skin-condition improving composition comprising vaccinium uliginosum extract and method for preparation thereof
TWI813986B (zh) 包含半乳寡醣或半乳寡醣和膠原蛋白三肽以改善免疫功能及皮膚狀況的功能性食品組合物和化妝品組合物
US11213472B2 (en) VEGFC production promoter
JP7832104B2 (ja) ヒアルロン酸産生促進剤
KR20250009609A (ko) Nmn, nad 및 atp를 포함하는 피부 상태 개선용 조성물
JP2017014205A (ja) トリプターゼ阻害剤組成物
JP3998085B2 (ja) ヒアルロン酸量増加促進剤
KR101993575B1 (ko) 테트라데칸을 유효성분으로 함유하는 피부주름 개선, 피부보습 개선 또는 탄력 증진용 조성물
JP2019052113A (ja) ヒアルロン酸産生促進剤及びヒアルロン酸産生促進用食品
EP4289434A1 (en) Barrier function improver
JP5253821B2 (ja) インテグリン、ビンキュリン促進剤及びナトリウム依存性ビタミンｃ輸送体（ｓｖｃｔ２）の発現促進剤
CN112972524B (zh) 五味子油抑制皮脂腺活性的应用
KR102256823B1 (ko) 도코사헥사노엔산 유도체를 함유하는 주름 개선, 아토피피부염 개선 및 피부 장벽 강화용 복합 조성물
CN110840785B (zh) 皮肤老化或皮肤皱纹改善用化妆品组合物
JP2011126814A (ja) コラーゲン産生促進剤、ヒアルロン酸産生促進剤、並びにコラーゲン産生促進およびヒアルロン酸産生促進剤
KR102039608B1 (ko) 미도드린을 포함하는 조성물 및 이의 용도
JPWO2022168846A5 (https=)
JP7475873B2 (ja) ディフェンシン発現促進剤
JP2013014627A (ja) ヘパリン結合性上皮成長因子様成長因子（ｈｂ−ｅｇｆ）生成促進剤
JP2014240361A (ja) 抗老化剤、美白剤、皮膚化粧料および飲食品
WO2022173012A1 (ja) スペルミジン産生促進剤
KR102634821B1 (ko) 피부 장벽 강화용 조성물

Legal Events

Date Code Title Description
RD03 Notification of appointment of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7423

Effective date: 20230616

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20230704

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20240220

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20250311

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250415

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20250729

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20251029

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20260224

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20260305

R150 Certificate of patent or registration of utility model

Ref document number: 7832104

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150